| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 3,800 | 1,325 |
| Net change in cash, cash equivalents and restricted cash | 4,566 | 5,193 |
| Cash and cash equivalents at beginning of period | 46,283 | - |
| Cash and cash equivalents at end of period | 50,849 | - |
FATE THERAPEUTICS INC (FATE)
FATE THERAPEUTICS INC (FATE)